<DOC>
	<DOCNO>NCT02026713</DOCNO>
	<brief_summary>All consecutive patient undergone PTCA period July 2013 December 2013 eligible enrol . Study population divide : Group 1 : smoker dual antiplatelet therapy ASA ( 100 mg day ) Prasugrel ( 10 mg die ) ; Group 2 : smoker dual antiplatelet therapy ASA ( 100 mg day ) Ticagrelor ( 90 mg twice day ) ; Control group : smoker dual antiplatelet therapy ASA ( 100 mg day ) Clopidogrel ( 75 mg day ) . Platelet function evaluate use validated method : VerifyNow System ( Accumetrics Inc. , San Diego , CA ) , point-of-care turbidimetry-based optical detection system measure platelet-induced aggregation . These value measure Platelet function , measure VerifyNow P2Y12 . All patient chronic dual antiplatelet therapy ( &gt; 1 month ) quit smoke 2 week period . Therefore PRU value obtain baseline ( enrollment time ) 2 week smoke cessation . Platelet reactivity express P2Y12 reaction unit ( PRU ) . PRU value &gt; 240 suggestive high platelet reactivity . Primary outcome : P2Y12 reaction unit ( PRU ) baseline two week quit smoking .</brief_summary>
	<brief_title>Potential Impact Cigarette Smoking Platelet Reactivity Patients Dual Antiplatelet Therapy With P2Y12 Inhibitors</brief_title>
	<detailed_description>All consecutive patient undergone PTCA period July 2013 December 2013 eligible enrol . Study population divide : Group 1 : smoker dual antiplatelet therapy ASA ( 100 mg day ) Prasugrel ( 10 mg die ) ; Group 2 : smoker dual antiplatelet therapy ASA ( 100 mg day ) Ticagrelor ( 90 mg twice day ) ; Control group : smoker dual antiplatelet therapy ASA ( 100 mg day ) Clopidogrel ( 75 mg day ) . Platelet function evaluate use validated method : VerifyNow System ( Accumetrics Inc. , San Diego , CA ) , point-of-care turbidimetry-based optical detection system measure platelet-induced aggregation . These value measure Platelet function , measure VerifyNow P2Y12 . All patient chronic dual antiplatelet therapy ( &gt; 1 month ) quit smoke 2 week period . Therefore PRU value obtain baseline ( enrollment time ) 2 week smoke cessation . Platelet reactivity express P2Y12 reaction unit ( PRU ) . PRU value &gt; 240 suggestive high platelet reactivity . Primary outcome : P2Y12 reaction unit ( PRU ) baseline two week quit smoking .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>All consecutive patient undergone PTCA institution period July 2013 December 2013 eligible enrol . smoker patient smoke 15Â±10 cigarette daily . patient dual antiplatelet therapy ASA P2Y12 inhibitor . recent ( &lt; 12 month ) percutaneous coronary intervention angiographicallyproven coronary artery disease people unable understand willing sign inform consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>